Brief Article
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 7, 2011; 17(13): 1753-1758
Published online Apr 7, 2011. doi: 10.3748/wjg.v17.i13.1753
Table 3 Results of ambulatory 24-h esophageal bilirubin monitoring in liver cirrhosis patients and controls (mean ± SD)
GroupNumber of bile reflux episodesNumber of bile reflux episodes lasting5 minMean time Abs > 0.14 (%)
TotalUprightSupine
Liver cirrhosis (n = 78)36.53 ± 9.31a4.09 ± 1.15a6.73 ± 1.15a3.32 ± 1.05a4.37 ± 1.44a
Child A (n = 28)27.32 ± 10.31a3.85 ± 1.34a5.12 ± 1.45a3.15 ± 0.92a4.12 ± 0.97a
Child B (n = 27)39.46 ± 18.31c4.11 ± 1.65c6.54 ± 1.21c3.37 ± 1.13c5.04 ± 1.11c
Child C (n = 23)48.54 ± 26.41e4.23 ± 2.14e7.32 ± 1.34e4.28 ± 1.22e5.52 ± 1.12e
Control (n = 30)12.76 ± 6.972.15 ± 1.361.98 ± 0.861.03 ± 0.230.83 ± 0.62